News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Data To Be Presented On Adherex Technologies Inc.'s Eniluracil At American Society of Clinical Oncology 2006 Annual Meeting
June 5, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Study results further support Adherex’s approach to the development of eniluracil + 5-FU
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
MORE ON THIS TOPIC
Partnered
Ending the Diagnostic Odyssey for Patients
December 11, 2024
·
4 min read
·
BioSpace Insights
CAR-T
J&J, Legend Shrug Off Carvykti’s Challengers With New Phase III Data
December 11, 2024
·
2 min read
·
Tristan Manalac
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
·
2 min read
·
Tristan Manalac
RSV
Moderna’s RSV Vaccines Run Into Safety Roadblock
December 11, 2024
·
2 min read
·
Tristan Manalac
